Management & Regulatory

Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?
Management & Regulatory Are Montana's New Rules Truly Closing Gaps in Hospital Oversight?

In an effort to crack down on perceived inadequacies in the oversight of nonprofit hospitals’ charitable activities, the state of Montana has rolled out new rules aimed at closing long-standing gaps. This move stems from a legislative audit conducted more than four years ago, which critiqued the

EPA and FDA's Vital Role in Public Health: Recent Regulatory Actions
Management & Regulatory EPA and FDA's Vital Role in Public Health: Recent Regulatory Actions

Imagine a world where the air we breathe, the water we drink, and the food we eat are all unchecked, teeming with unseen hazards. For many, this is a nightmarish scenario, yet it highlights the importance of regulatory bodies such as the Environmental Protection Agency (EPA) and the Food and Drug

Is BioMarin's $60M Investment in Cork a Game-Changer for Biopharma?
Management & Regulatory Is BioMarin's $60M Investment in Cork a Game-Changer for Biopharma?

BioMarin Pharmaceutical Inc. has made headlines with its announcement of a significant €60 million investment geared towards the expansion of its state-of-the-art facility located in Shanbally, Co. Cork. This ambitious expansion plan encompasses the construction of a new four-story laboratory

How Did Maine Address Mental Health in Education During COVID-19?
Management & Regulatory How Did Maine Address Mental Health in Education During COVID-19?

The COVID-19 pandemic brought unprecedented challenges to educational systems worldwide, and Maine was no exception. When schools closed in March 2020, the Maine Department of Education (DOE) quickly recognized the need to address the mental health of both students and educators. This article

Freya Biosciences Secures $11.8M to Tackle Recurrent Bacterial Vaginosis
Management & Regulatory Freya Biosciences Secures $11.8M to Tackle Recurrent Bacterial Vaginosis

Freya Biosciences, a transatlantic biotech company specializing in women's health, has successfully secured a substantial $10.4 million investment from the Bill & Melinda Gates Foundation, along with an additional $1.4 million in financing from the Export and Investment Fund of Denmark. This

How Will the Mesenchymal Stem Cells Market Expand by 2032?
Management & Regulatory How Will the Mesenchymal Stem Cells Market Expand by 2032?

The Mesenchymal Stem Cells (MSC) market is experiencing rapid growth, driven by an aging global population, advancements in regenerative medicine, and technological innovations in biotechnology. Valued at USD 3.2 billion in 2023, the market is anticipated to reach USD 9.72 billion by 2032, with a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later